Objective: The main objective of this study was to investigate the psychometric properties of the Zung Self-Rating Depression Scale (SDS) and evaluate screening parameters capability of the SDS with the Beck Depression Inventory (BDI-21) among the elderly population. Design: A population-based study Setting: Community Subjects: 520 adults, aged 72–73 years, living in the city of Oulu, Finland. Main outcome measures: The screening parameters of the SDS questions and BDI-21 for detecting severity of depression. The Mini Neuropsychiatric Interview for diagnosing major depression. Results: The optimal cut-off point for the SDS was 39. The sensitivity and specificity parameters for this cut-off point were 79.2% (95% CI 57.8–92.9) and 72.2% (95% CI 67.9–76.1), respectively. Positive and negative predictive values were 12.5% (95% CI 7.7–18.8) and 98.6% (95% CI 96.7–99.5), respectively. Moreover, there was no statistically significant difference in diagnostic accuracy indices of the cut-off points 39 and 40. In a receiver operating characteristic analysis, the area under the curve was 0.85 (95%CI 0.77–0.92) for the SDS total score and 0.89 (95% CI 0.83-0.96) for the BDI-21 ( p = 0.137). Conclusion: Using the traditional cut-off point, the SDS was convenient for identifying clinically meaningful depressive symptoms in an elderly Finnish population when compared with the BDI-21 which is one of the most commonly used depression screening scales. The sensitivity and specificity of these two screening tools are comparable. Based on our study, the SDS is convenient for identifying clinically meaningful depressive symptoms among older adults at the community level. Key points The widely used Zung Self-Rating Depression Scale (SDS) has not previously been validated among elderly people at the community level. The sensitivity and specificity of SDS (cut-off point 39) were 79.2% and 72.2%. The positive and negative predictive values for SDS were 12.5% and 98.6%. SDS is convenient for identifying major depression in an elderly population and regarding sensitivity and specificity comparable to BDI-21.
Morning, day, or evening chronotypes differ by the circadian timing of alertness and the preferred timing of sleep. It has been suggested that evening chronotype is associated with low physical activity (PA) and high sedentary time (SED). Our aim was to investigate whether such an association is confirmed by objectively measured PA and SED. In 46‐year follow‐up of the Northern Finland Birth Cohort 1966 study, total PA (MET min/day) and SED (min/day) among 5156 participants were determined using wrist‐worn accelerometers for 14 days. We used the shortened Morningness‐Eveningness Questionnaire to define participants' chronotypes. As covariates, we used self‐reported physical strenuousness of work, health, and demographics, and clinical measures. We used adjusted general linear models (B coefficients with 95% confidence intervals, CI) to analyze how chronotype was related to total PA or SED. As compared to evening chronotype, men with day and morning chronotypes had higher total PA volumes (adjusted B 75.2, 95% CI [8.1, 142.4], P = .028, and 98.6, [30.2, 167.1], P = .005). Men with day and morning chronotypes had less SED (−35.8, [−53.8, 17.8], P < .0001, and − 38.6, [−56.9, −20.2], P < .0001). Among women, morning chronotype was associated with higher total PA (57.8, [10.5, 105.0], P = .017), whereas no association between chronotype and SED emerged. Evening chronotype was associated with low objectively measured PA in both sexes and with high SED in men, even after adjustments for established potential confounders. Chronotype should be considered in PA promotion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.